ITRACONZOLE USP 1%W/W,OFLOXACIN I.P 0.75% W/W,ORINDAZOLE I.P 2.0%,CLOBETSOLE PROPIONATE I.P 0.05% W/W,METHYLPARABEN(PREESERVATIVE) I.P0.20%W/W,PROPYLBPARABEN (PREESERVATIVE)I.P0.02 %W/W IN CREAM BASE Q,S
A comprehensive topical formulation combining antifungal, antibacterial, antiprotozoal, and anti-inflammatory agents for effective management of mixed skin infections associated with redness, itching, irritation, and inflammation.
Key Benefits
- Broad-spectrum action against fungal and bacterial skin infections
- Helps relieve itching, redness, swelling, and irritation
- Supports faster healing of infected skin lesions
- Effective in managing inflammatory dermatoses with secondary infection
- Smooth cream base ensures easy application and better skin penetration
Mechanism of Action
Itraconazole is a broad-spectrum antifungal agent that inhibits fungal cell membrane synthesis, helping eliminate fungal infections. Ofloxacin is a fluoroquinolone antibiotic that prevents bacterial growth by inhibiting bacterial DNA replication. Ornidazole provides antiprotozoal and antimicrobial activity against susceptible microorganisms. Clobetasol Propionate, a potent corticosteroid, helps reduce inflammation, redness, itching, and allergic reactions associated with skin infections.
Indications
Indicated for the management of:
- Mixed fungal and bacterial skin infections
- Infected dermatitis and eczema
- Ringworm and superficial fungal infections with inflammation
- Itching, redness, and allergic skin conditions associated with infection
- Secondary infected inflammatory dermatoses as advised by the physician